(Q41665541)

6 October 2017

1 reference

title

Pathophysiology of vitiligo (English)

1 reference

6 October 2017

1 reference

1 reference

Castanet J

1

1 reference

6 October 2017

Ortonne JP

series ordinal

2

1 reference

6 October 2017

publication date

1 November 1997

1 reference

6 October 2017

published in

Clinics in Dermatology

1 reference

6 October 2017

volume

15

1 reference

6 October 2017

issue

6

1 reference

6 October 2017

page(s)

845-851

1 reference

Vitiligo: where do we stand?

6 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900125-9

7 January 2021

Review of the etiopathomechanism of vitiligo: a convergence theory

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900125-9

7 January 2021

Serum antibodies in vitiligo patients

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900125-9

7 January 2021

Presence or absence of melanocytes in vitiligo lesions: an immunohistochemical investigation

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900125-9

7 January 2021

Keratinocyte damage in vitiligo

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900125-9

7 January 2021

Ultrastructural studies of vitiligo with inflammatory raised borders

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900125-9

7 January 2021

Extracellular granular material and degeneration of keratinocytes in the normally pigmented epidermis of patients with vitiligo.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900125-9

7 January 2021

Epidermal Changes in Active Vitiligo

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900125-9

7 January 2021

Effect of bursectomy on development of a spontaneous postnatal amelanosis

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900125-9

7 January 2021

Delayed-amelanotic (DAM or Smyth) chicken: melanocyte dysfunction in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900125-9

7 January 2021

A mouse model for vitiligo.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900125-9

7 January 2021

Increase in retinyl palmitate concentration in eyes and livers and the concentration of interphotoreceptor retinoid-binding protein in eyes of vitiligo mutant mice

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900125-9

7 January 2021

Low ICAM-1 expression in the epidermis of depigmenting C57BL/6J-mivit/mivit mice: a possible cause of muted contact sensitization

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900125-9

7 January 2021

Premature avian melanocyte death due to low antioxidant levels of protection: fowl model for vitiligo.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900125-9

7 January 2021

Genetics and molecular biology of mouse pigmentation

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900125-9

7 January 2021

Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900125-9

7 January 2021

Detection of Antibodies to Melanocytes in Vitiligo by Specific Immunoprecipitation

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900125-9

7 January 2021

Evidence for immunologic mechanisms in human vitiligo: patients' sera induce damage to human melanocytes in vitro by complement-mediated damage and antibody-dependent cellular cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900125-9

7 January 2021

Coexistence and relationship of antikeratinocyte and antimelanocyte antibodies in patients with non-segmental-type vitiligo

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900125-9

7 January 2021

Identification of pigment cell antigens defined by vitiligo antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900125-9

7 January 2021

Characterization of vitiligo antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900125-9

7 January 2021

The role of tyrosinase in autoimmune vitiligo

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900125-9

7 January 2021

Correlation between vitiligo antibodies and extent of depigmentation in vitiligo

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900125-9

7 January 2021

Relation Between the Incidence and Level of Pigment Cell Antibodies and Disease Activity in Vitiligo

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900125-9

7 January 2021

Cytolytic antibodies to melanocytes in vitiligo

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900125-9

7 January 2021

Immunopathology of vitiligo vulgaris, Sutton's leukoderma and melanoma-associated vitiligo in relation to steroid effects. II. The IgG and C3 deposits in the skin

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900125-9

7 January 2021

Melanocytes and Langerhans cells in aged versus young skin before and after transplantation onto nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900125-9

7 January 2021

In Vivo Destruction of Melanocytes by the IgG Fraction of Serum from Patients with Vitiligo

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900125-9

7 January 2021

Medical management of stage IV malignant melanoma. Medical issues

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900125-9

7 January 2021

Vitiligo-like lesions following immunotherapy with IFN alpha and IL-2 in melanoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900125-9

7 January 2021

Autoimmune disorders and interleukin-2 therapy: a step toward 'unanswered questions'

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900125-9

7 January 2021

Natural killer cell and lymphokine-activated killer cell activity against melanocytes in vitiligo

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900125-9

7 January 2021

Abnormal expression of MHC class II and ICAM-1 by melanocytes in vitiligo

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900125-9

7 January 2021

Nonsegmental vitiligo: decrease of the CD45RA+ T-cell subset and evidence for peripheral T-cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900125-9

7 January 2021

An immunohistological study of cutaneous lymphocytes in vitiligo.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900125-9

7 January 2021

Structural aberration of the rough endoplasmic reticulum and melanosome compartmentalization in long-term cultures of melanocytes from vitiligo patients

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900125-9

7 January 2021

Biologic characteristics of cultured human vitiligo melanocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900125-9

7 January 2021

Age of onset in vitiligo: relationship with HLA supratypes.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900125-9

7 January 2021

Melanocyte mitogens induce both melanocyte chemokinesis and chemotaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900125-9

7 January 2021

Apoptosis: does stress kill?

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900125-9

7 January 2021

Vitiligo – A Window in the Darkness

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900125-9

7 January 2021

Morphologic observations on the dermal nerves in vitiligo: an ultrastructural study

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900125-9

7 January 2021

Innervation of melanocytes in human skin.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900125-9

7 January 2021

Plasma α-melanocyte-stimulating hormone, β-endorphin, met-enkephalin, and natural killer cell activity in vitiligo

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900125-9

7 January 2021

Cytomegalovirus DNA identified in skin biopsy specimens of patients with vitiligo

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900125-9

7 January 2021

Melanocyte destruction and repopulation in vitiligo

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900125-9

7 January 2021

KIT expression reveals a population of precursor melanocytes in human skin

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2897%2900125-9

7 January 2021

10.1016/S0738-081X(97)00125-9

Identifiers

DOI

1 reference

6 October 2017

1 reference